New research identifies promising drug combination for multiple myeloma treatment
HMN 2024 – New research from the Royal College of Surgeons in Ireland has found that venetoclax, a medication currently approved for leukemia, provides benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers a new avenue of treatment options for the currently incurable disease. Multiple myeloma (MM) is a type of […]